» Articles » PMID: 36034561

Are Infections in Children with Juvenile Idiopathic Arthritis More Frequent Than in Healthy Children? A Prospective Multicenter Observational Study

Abstract

Background: Children with juvenile idiopathic arthritis (JIA) might be at a higher risk of infection. Our objectives are to describe and compare infection rates in patients with JIA vs. healthy patients.

Methods: A prospective, multicenter observational study was performed in Spain from January 2017 to June 2019. Patients with JIA from 7 participating hospitals and children without JIA (siblings of patients with JIA, and non-JIA children from primary health centers) were followed up with quarterly questionnaires to record infection episodes. Tuberculosis, herpes zoster, and infections requiring hospital admission were considered severe infections. Rates of infection (episodes/patient/year) were compared using a generalized estimating equations model.

Results: A total of 371 children (181 with and 190 without JIA) were included. The median age was 8.8 years (IQR 5.5-11.3); 75% of the patients with JIA received immunosuppressive treatment (24% methotrexate, 22% biologic, 26% both). A total of 667 infections were recorded; 15 (2.2%) were considered severe. The infection rate was 1.31 (95%CI 1.1-1.5) in JIA and 1.12 (95%CI 0.9-1.3) in non-JIA participants ( = 0.19). Age <4 years increased the infection rate by 2.5 times (2.72 vs. 1.12, < 0.001) in both groups. The most frequent infection sites were upper respiratory (62.6% vs. 74.5%) and gastrointestinal (18.8% vs. 11.4%). There were no differences in severe infections (2.5% vs. 2%, = 0.65) between the groups. In children with JIA, younger age and higher disease activity (JADAS71) were associated with a higher infection rate.

Conclusion: We found no differences in the infection rate or infection severity between patients with and without JIA. Most infections were mild. An age younger than 4 years increased the infection risk in both groups. Higher disease activity was associated with a higher infection rate.

Citing Articles

Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8 T cell repertoire response to influenza vaccination.

Sabbagh S, Haribhai D, Gershan J, Verbsky J, Nocton J, Yassai M Front Immunol. 2024; 15:1306490.

PMID: 38873594 PMC: 11169902. DOI: 10.3389/fimmu.2024.1306490.

References
1.
Furer V, Rondaan C, Heijstek M, Agmon-Levin N, van Assen S, Bijl M . 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2019; 79(1):39-52. DOI: 10.1136/annrheumdis-2019-215882. View

2.
Davies R, Southwood T, Kearsley-Fleet L, Lunt M, Hyrich K . Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Arthritis Rheumatol. 2015; 67(9):2487-94. PMC: 5049649. DOI: 10.1002/art.39197. View

3.
Au K, Reed G, Curtis J, Kremer J, Greenberg J, Strand V . High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011; 70(5):785-91. DOI: 10.1136/ard.2010.128637. View

4.
Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva E . Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries. Arthritis Res Ther. 2018; 20(1):285. PMC: 6307151. DOI: 10.1186/s13075-018-1780-z. View

5.
Horneff G . Biologic-associated infections in pediatric rheumatology. Curr Rheumatol Rep. 2015; 17(11):66. DOI: 10.1007/s11926-015-0542-z. View